Eevia Health Plc has received a sales order for EUR 69,000 from a new Australian customer for Feno-Sambucus 14, a standardized Elderberry extract. Eevia received the sales order from an Australian customer through their exclusive distributor in Australia, Ingredient Plus. The end customer is a one of the largest contract manufacturing groups in Australia with sales across Southeast Asia.

This is a new customer for Eevia. This first sales order is larger than typical start orders. This customer is known for large volumes, steady business, and reordering.

The product is in stock and Eevia will ship immediately. Eevia expects an excellent trajectory with this new customer and significant repeat orders. Feno-Sambucus?

14 is an elderberry extract standardized at 14% anthocyanins. Eevia uses a unique purification technology that purifies the product based on chemical class. Contrary to competitors, Eevia's manufacturing process leaves other critical bioactive compounds than anthocyanins, such as proanthocyanidins (PACs), in the extract.

This feature differentiates Eevia's elderberry extract from other elderberry extracts made using membrane filtration technology in the market. These technologies and processing approaches purifies the extract based on molecular size and reduces the presence of large bioactive compounds such as PACs, while Eevia purifies based on affinity of phenolic compounds. This technology retains much more polyphenols in the extract.